Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Other financing activities (2020 - 2024)

Beauty Health (SKIN) has disclosed Other financing activities for 4 consecutive years, with -$302000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Other financing activities rose 15.17% to -$302000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was -$884000.0, a 51.89% decrease, with the full-year FY2024 number at -$302000.0, changed N/A from a year prior.
  • Other financing activities was -$302000.0 for Q4 2024 at Beauty Health, up from -$356000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $21.3 million in Q3 2021 to a low of -$356000.0 in Q4 2023.
  • A 4-year average of $3.5 million and a median of $3686.5 in 2020 define the central range for Other financing activities.
  • Peak YoY movement for Other financing activities: skyrocketed 9044.59% in 2021, then increased 15.17% in 2024.
  • Beauty Health's Other financing activities stood at $465909.0 in 2020, then skyrocketed by 4480.51% to $21.3 million in 2021, then crashed by 101.67% to -$356000.0 in 2023, then rose by 15.17% to -$302000.0 in 2024.
  • Per Business Quant, the three most recent readings for SKIN's Other financing activities are -$302000.0 (Q4 2024), -$356000.0 (Q4 2023), and -$226000.0 (Q3 2023).